agilon health, inc. (NYSE:AGL - Get Free Report)'s share price traded up 8.6% during trading on Thursday . The company traded as high as $3.71 and last traded at $3.73. 7,115,106 shares were traded during mid-day trading, an increase of 32% from the average session volume of 5,374,423 shares. The stock had previously closed at $3.43.
Analyst Ratings Changes
A number of research firms recently commented on AGL. Stifel Nicolaus lowered their price target on shares of agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a report on Tuesday, November 12th. JMP Securities cut shares of agilon health from an "outperform" rating to a "market perform" rating in a research report on Monday, November 11th. Needham & Company LLC assumed coverage on shares of agilon health in a report on Friday, January 10th. They issued a "hold" rating for the company. Royal Bank of Canada restated an "outperform" rating and set a $3.00 target price on shares of agilon health in a report on Tuesday, November 19th. Finally, Macquarie started coverage on shares of agilon health in a research note on Monday, December 16th. They set a "neutral" rating and a $3.00 price objective for the company. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $4.03.
Read Our Latest Stock Report on agilon health
agilon health Stock Performance
The firm has a fifty day simple moving average of $2.46 and a 200 day simple moving average of $3.39. The company has a market capitalization of $1.39 billion, a price-to-earnings ratio of -3.60 and a beta of 0.66. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.
agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion for the quarter, compared to analysts' expectations of $1.47 billion. During the same period in the prior year, the company posted ($0.06) EPS. On average, analysts anticipate that agilon health, inc. will post -0.59 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other agilon health news, Director Diana Mckenzie acquired 12,500 shares of the company's stock in a transaction that occurred on Monday, November 25th. The shares were purchased at an average price of $2.28 per share, with a total value of $28,500.00. Following the completion of the acquisition, the director now directly owns 51,319 shares of the company's stock, valued at approximately $117,007.32. The trade was a 32.20 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Karen Mcloughlin purchased 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 90,000 shares of company stock worth $198,100 over the last three months. Company insiders own 3.20% of the company's stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. acquired a new position in agilon health in the 3rd quarter worth $28,000. Oak Thistle LLC acquired a new position in agilon health during the 4th quarter valued at approximately $25,000. City State Bank acquired a new stake in shares of agilon health in the 3rd quarter worth about $52,000. Ieq Capital LLC bought a new stake in agilon health during the 4th quarter valued at $26,000. Finally, Aigen Investment Management LP acquired a new position in shares of agilon health during the third quarter valued at approximately $79,000.
About agilon health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
